Pharmacoeconomics of chronic nonmalignant pain

PharmacoEconomics

Volumn 10, Issue 4, 1996, Pages 356-377

  Zagari, Martin J ^a   Mazonson, Peter D ^a   Longton, William C ^b  

^a Technology Assessment Group   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; FENTANYL; HYDROCODONE; IBUPROFEN; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; SALSALATE;

CHRONIC PAIN; CLINICAL TRIAL; HEALTH CARE COST; HUMAN; PHARMACOECONOMICS; PRIORITY JOURNAL; REVIEW;

EID: 0029813868     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199610040-00005     Document Type: Review

References (139)

1. Latham J, Davis BD. The socioeconomic impact of chronic pain. Disab Rehab 1994; 16 (1): 39-44
2. Schug SA, Large RG. Economic considerations in pain management. Pharmacoeconomics 1993; 3 (4): 260-7
3. Crook J, Rideout E, Browne G. The prevalence of pain complaints in a general population. Pain 1984; 18: 299-314
4. Brattberg G, Thorslund M, Wikman A. The prevalence of pain in a general population: the results of a postal survey in a county of Sweden. Pain 1989; 37: 215-22
5. Bonica JJ. The management of pain. 2nd ed. Philadelphia: Lea and Febiger, 1990: 159-97
6. Von Korff M, Wagner EH, Dworkin SF, et al. Chronic pain and use of ambulatory health care. Psychosom Med 1991; 53: 61-79
7. Hitchcock LS, Ferrell BR, McCaffery M. The experience of chronic non-malignant pain. J Pain Symptom Manage 1994; 9: 312-8
8. James FR, Large RG. Chronic pain and the use of health services. N Z Med J 1992; 105: 196-8
9. Grichnik KP, Ferrante MF. The difference between acute and chronic pain. Mt Sinai J Med 1991; 58: 217-20
10. Koch H. The management of chronic pain in office-based ambulatory care: National Ambulatory Medical Care Survey. Advance Data for Vital and Health Statistics, no. 123, DHHS publication no. (PHS) 86-1250. Hyattsville (MD): Public-Health Service, 1986
11. World Health Organization. Cancer pain relief and palliative care: report of a WHO expert committee. Technical report series 804. Geneva: World Health Organization, 1990
12. Bradley JD, Brandt KD, Katz BP, et al. Comparison of an inflammatory dose of ibuprofen, an a analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87-91
13. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993; 36: 1196-206
14. Hochberg MC, Altman RD, Brandt, KD et al. Guidelines for the medical management of osteoarthritis. Arthritis Rheum 1995; 38: 1535-40
15. Management of cancer pain: clinical practice guideline, no. 9, US Department of Health and Human Services, 1994
16. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. JAMA 1995; 274 (23): 1870-3
17. Wynne HA, Campbell M. Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs). Pharmacoeconomics 1993; 3: 107-23
18. de Pouvourville G. Preventing NSAID-induced gastrointestinal toxicity. Pharmacoeconomics 1995; 7: 99-110
19. Smalley WE, Griffin MR, Fought RL, et al. Effect of a priorauthorization requirement on the use of nonsteroidal anti-inflammatory drugs by Medicaid patients. N Engl J Med 1995;332: 1612-7
20. Kolodney AL, Klipper A. Final report on the cost of treating arthritic disease: comparison between salicylates and non-salicylate nonsteroidal anti-inflammatory drugs. Semin Arthritis Rheum 1985; 14 (1 Suppl.): 20S-4S
21. Greene JM, Winickoff RN. Cost-conscious prescribing on nonsteroidal anti-inflammatory drugs for adults with arthritis. Arch Intern Med 1992; 152: 1995-2002
22. de Pouvourville G. The economic consequences of NSAID-induced gastropathy: the French context. Scand J Rheumatol 1992; 96 Suppl.: 49-53
23. Hillman AL, Bloom BS. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. Arch Intern Med 1989; 149: 2061-5
24. Jonsson B, Haglund U. Cost-effectiveness of misoprostol in Sweden. Int J Technol Assess Health Care 1992; 8: 234-44
25. Carrin GJ, Torfs KE. Economic evaluation of prophylactic treatment with misoprostol in osteoarthritic patients treated with NSAIDs: the case in Belgium. Rev Epidemiol Med Soc Sante Publique 1990; 38: 187-99
26. Barradell LB, Whittington R. Benfield P. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs. Pharmacoeconomics 1993; 3: 140-70
27. Carson JL, Strom BL, Morse ML, et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987; 147: 1054-9
28. Grahame R. Transdermal non-steroidal anti-inflammatory agents. Br J Clin Pract 1995; 49: 33-5
29. White B, Sanders SH. The influence of patients' pain intensity ratings of antecedent reinforcement of pain talk or well talk. J Behav Ther Exp Psychiatry 1986; 17: 155-9
30. Portenoy RK. Chronic opioid therapy in non-mulignant pain. J Pain Symptom Manage 1990 Feb; Suppl. 1: 46S-62S
31. Portenoy RK, Foley KM. The chronic use of opioid analgesics in nonmalignant pain. Pain 1986; 25: 171-86
32. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984; 19: 1379-82
33. Taub A. Opioid analgesia in the treatment of chronic intractable pain of non-neoplastic origin. In: Kitahata LM, Collins D, editors. Narcotic analgesics in anesthesiology. Baltimore: Williams and Wilkins, 1982: 199-208
34. Brena SF, Sanders SH. Opioids in non-malignant pain: questions in search of answers. Clin J Pain 1991; 7: 342-5
35. Arner S, Myerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33: 11-23
36. McQuay HJ, Jadad AR, Carroll D, et al. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia 1992; 47: 757-67
37. Fainsinger R, Schoeller T, Bruera E. Methadone in the management of cancer pain: a review. Pain 1993; 52: 137-45
38. Boreau F, Saudubray F, D'Arnoux C, et al. A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain. J Pain Symptom Manage 1992; 7: 393-99
39. Chary S, Goughnour BR, Moulin DE, et al. The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain. J Pain Symptom Manage 1994; 9: 363-71
40. Hays H, Hagen N, Thirlwell M, et al. Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer 1994; 74: 1808-16
41. Ferrell B, Wisdom C, Wenzl C, et al. Effects of controlled-release morphine on quality-of-life for cancer pain. Oncol Nurs Forum 1989; 16: 521-6
42. Bloor K, Leese B, Maynard A. The costs of managing severe cancer pain and potential savings from transdermal administration. Eur J Cancer 1994; 30A: 463-8
43. Byas-Smith MG, Max MB, Muir J, et al. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain 1995; 60: 267-74
44. Egbunike IG, Chaffee B. Antidepressants in the management of chronic pain states. Pharmacotherapy 1990; 10: 262-70
45. Zeigler D, Lynch SA, Muir J, et al. Transdermal clonidine versus placebo in painful diabetic neuropathy. Pain 1992; 48: 403-8
46. Davis KD, Treede RD, Raja SN, et al. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991; 47: 309-17
47. Carroll D, Jadad A, King V, et al. Single-dose, randomized, double-blind, double-dummy cross-over comparison of extradural and i.v. clonidine in chronic pain. Br J Anaesth 1993; 71: 665-9
48. Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982; 54: 501-5
49. Edwards WT. Intravenous lidocaine in the management of various chronic pain states: a review of 211 cases. Reg Anaesth 1985; 10: 1-6
50. Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991; 45: 145-8
51. Kastrup J, Angelo H, Petersen P, et al. Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion. Br Med J Clin Res Ed 1986 Jan 18; 292: 173
52. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988 Jan; I (8575-6): 9-11
53. Chabal C, Jacobson L, Mariano A, et al. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992; 76: 513-7
54. Ellenberg M. Treatment of diabetic neuropathy with diphenylhydantoin. NY State J Med 1968; 68: 2653-5
55. Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991; 74: 949-51
56. Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995; 10: 265-6
57. Backonja M, Arndt G, Gombar KA, et al. Response of chronic neuropathic syndrome to ketamine: a preliminary study. Pain 1994; 56: 51-7
58. Eide K, Stubhaug A, Oye I, et al. Continuous subcutaneous administration of N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post herpetic neuralgia. Pain 1995; 61: 221-8
59. Price DD, Mao J, Frenk H, et al. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59: 165-74
60. Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994; 35 Suppl.: S50-3
61. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326 (19): 1250-60
62. + channels: local anesthetics, antiarrhythmics and anticonvulsants. TIPS 1987; 8: 57-64
63. McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127-33
64. Hassenbusch SJ, Stanton-Hicks MD, Soukup J, et al. Sufentanil citrate and morphine/bupivacaine as alternative agents in chronic epidural infusions for intractable non-cancer pain. Neurosurgery 1991; 29: 76-81
65. Follett KA, Hitchon PW, Piper J, et al. Response of intractable pain to continuous intrathecal morphine: a retrospective study. Pain 1992; 49: 21-5
66. Auld AW, Murdoch DM, O'Laughlin KA. Intraspinal narcotic analgesia: pain management in the failed laminectomy syndrome. Spine 1987; 12: 953-4
67. Penn RD, Paice JA. Chronic intrathecal morphine for intractable pain. J Neurosurg 1987; 67: 182-6
68. Rauck RL, Eisenach JC, Jackson K, et al. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993; 79: 1163-9
69. Coombs DW, Saunders RL, Gaylor MS, et al. Relief of continuous chronic pain by intraspinal narcotics infusion via an implanted reservoir. JAMA 1983; 250: 2336-9
70. Nance P, Schryvers O, Schmidt B, et al. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995; 22: 22-9
71. Kwan JW. Use of infusion devices for epidural or intrathecal administration of spinal opioids. Am J Hosp Pharm 1990; 47 Suppl. 1: S18-23
72. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 1991; 6: 368-73
73. Bel S, Bauer BL. Dorsal column stimulation (DCS): cost to benefit analysis. Acta Neurochir 1991; 52: 121-3
74. Cousins MJ, Bridenbaugh, PO. Neural blockade in clinical anesthesia and management of pain. 2nd edition. Philadelphia: JB Lippincott Co., 1988: 1085-108
75. North RB, Ewend MG, Lawton MT, et al. Failed back surgery syndrome: 5-year follow-up after spinal cord stimulator implantation. Neurosurgery 1991; 28: 692-9
76. LeDoux MS, Langford KH. Spinal cord stimulation of the failed back syndrome. Spine 1993; 18: 191-4
77. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 1992; 49: 221-30
78. Carosella AM, Lackner JM, Feuerstein M. Factors associated with early discharge from a multidisciplinary work rehabilitation program for chronic low back pain. Pain 1994; 57: 69-76
79. Tota-Faucette ME, Gil KM, Williams DA, et al. Predictors of response to pain management treatment: the role of family environment and changes in cognitive processes. Clin J Pain 1993; 9: 115-23
80. Jensen MP, Turner JA, Romano JM. Correlates of improvement in multidisciplinary treatment of chronic pain. J Consult Clin Psychol 1994; 62: 172-9
81. Lipchik GL, Milles K, Covington EC. The effects of multidisciplinary pain management treatment on locus of control and pain beliefs in chronic non-terminal pain. Clin J Pain 1993 Mar; 9: 49-57
82. Deyo RA, Diehl AK. Psychosocial predictors of disability in patients with low back pain. J Rheumutol 1988; 15: 1557-64
83. King SA, Snow BR. Factors for predicting premature termination from a multidisciplinary inpatient chronic pain program. Pain 1989; 39: 281-7
84. Turk DC, Rudy TE, Sorkin BA, et al. Neglected factors in chronic pain treatment outcome studies: determination of success. Pain 1993; 3: 7-25
85. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993; 36: 439-46
86. Gallagher R, Rauh V, Haugh L, et al. Determinants of return to work among low back pain patients. Pain 1989; 39: 55-67
87. Deardorff WW, Rubin HS, Scott DW, et al. Comprehensive multidisciplinary treatment of chronic pain: a follow-up study of treated and non-treated groups. Pain 1991; 45: 35-43
88. Linton SJ, Bradley LA. An 18-month follow-up of a secondary prevention program for back pain: help and hindrance factors related to outcome maintenance. Clin J Pain 1992; 8: 227-36
89. Caudill M, Schnable R, Zuttermeister P, et al. Decreased clinic use by chronic pain patients: response to behavioral medicine intervention. Clin J Pain 1991; 7: 305-10
90. Luscombe FE, Wallace L, Williams J, et al. A district general hospital pain management programme - first year experiences and outcomes. Anesthesia 1995; 50: 114-7
91. Gutkin AJ, Holborn SW, Walker JR, et al. Cost-effectiveness of home relaxation training for tension headaches. J Behav Ther Exp Psychiatry 1994; 25: 69-74
92. Frymoyer JW, Cats-Baril WL. An overview of the incidence and costs of low back pain. Orthop Clin North Am 1991; 22: 263-71
93. de Girolamo G. Epidemiology and social costs of low back pain and fibromyalgia. Clin J Pain 1991; 7 Suppl. 1: S1-7
94. Taylor H, Curran N. The Nuprin pain report. New York: Louis Harris and Associates, 1985
95. Borenstein D. Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. Curr Opin Rheumatol 1995; 7: 141-6
96. Webster BS, Snook SH. The cost of 1989 workers' compensation low back pain claims. Spine 1994; 19: 1111-5, discussion 1116
97. Liu AC, Byrne E. Cost of care for ambulatory patients with low back pain. J Fam Pract 1995; 40: 449-55
98. Deyo RA, Rainville J, Kent DI. What can the history and physical examination tell us about low back pain? JAMA 1992; 268: 760-5
99. Carey TS, Evans A, Hadler N, et al. Care-seeking among individuals with chronic low back pain. Spine 1995; 20: 312-7
100. Taylor VM, Deyo RA, Cherkin DC, et al. Low back pain hospitalization: recent United States trends and regional variations. Spine 1994; 19: 1207-13
101. Elam KC, Cherkin DC, Deyo RA. How emergency physicians approach low back pain: choosing costly options. J Emerg Med 1995 Mar-Apr; 13: 143-50
102. Frymoyer JW, Cats-Baril W. Predictors of low back pain disability. Clin Orthop 1987; 221. 89-98
103. Andersson GBJ, Svensson HO, Oden A. The intensity of work recovery in low back pain. Spine 1983; 8: 880
104. Biering-Sorenson F. Low back trouble in a general population of 30-, 40-, 50-, and 60-year old men and women: study design, representativeness and haste results. Dan Med Bull 1982; 29: 239
105. Von Korff M, Barlow W, Cherkin D, et al. Effects of practice style in managing back pain. Ann Intern Med 1994; 121: 187-95
106. AHCPR Guidelines. Acute low back problems in adults: assessment and treatment. No. 95-0643. 1994; 1-25
107. Assendelft WJ, Bouter LM. Does the goose really lay golden eggs? A methodological review of workmen's compensation studies. J Manipulative Physiol Ther 1993; 16: 161-8
108. Bergemann BW, Cichoke AJ. Cost-effectiveness of medical vs. chiropractic treatment of low-back injuries. J Manipulative Physiol Ther 1980; 3: 143-7
109. Dean H, Schmidt R. A comparison of the cost of chiropractors versus alternative medical practitioners. Richmond: Virginia Chiropractic Association, 1992
110. Jarvis KB, Phillips RB, Morris EK. Cost per case comparison of back injury claims of chiropractic versus medical management for conditions with identical diagnostic codes. J Occup Med 1991; 33: 847-52
111. Johnson MR, Schultz MK, Ferguson AC. A comparison of chiropractic, medical and osteopathic care for work-related sprains and strains. J Manipulative Physiol Ther 1989; 12: 335-44
112. Nyiendo J, Lamm L. Disabling low back Oregon workers' compensation claims: part I. Methodology and clinical categorization of chiropractic and medical cases. J Manipulative Physiol Ther 1991; 14: 177-84
113. Nyiendo J. Disabling low back Oregon workers' compensation claims: part II. Time loss. J Manipulative Physiol Ther 1991; 14: 231-9
114. Nyiendo J. Disabling low back Oregon workers' compensation claims: part III. Diagnostic and treatment procedures and associated costs. J Manipulative Physiol Ther 1991; 14: 287-97
115. Stano M. A comparison of health care costs for chiropractic and medical patients. J Manipulative Physiol Ther 1993; 16: 291-9
116. Wolk S. An analysis of Florida workers' compensation medical claims for back-related injuries. American Chiropractic Association Journal 1988; 27: 50-9
117. Shekelle PG, Markovich M, Louie R. Comparing the costs between provider types of episodes of back pain care. Spine 1995; 20: 221-7
118. Carey TS, Garrett J, Jackman A, et al. The outcomes and costs of care for acute low back pain among patients seen by primary care practitioners, chiropractors, and orthopedic surgeons: the North Carolina Back Pain Project. N Engl J Med 1995; 333: 913-7
119. Hourigan PG, Weatherley CR. Initial assessment and follow-up by a physiotherapist of patients with back pain referred to a spinal clinic. J R Soc Med 1994; 87: 213-4
120. Schroth WS, Schectman JM, Elinsky EG, et al. Utilization of medical services for the treatment of acute low back pain: conformance with clinical guidelines. J Gen Intern Med 1992; 7: 486-91
121. Jensen MC, Brant Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994; 331: 69-73
122. Boden SD, Davis DO, Dina TS, et al. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J Bone Joint Surg Am 1990; 72: 403-8
123. Jette AM, Smith K, Haley SM, et al. Physical therapy episodes of care for patients with low back pain. Phys Ther 1994; 74: 101-10
124. Volinn E, Turczyn KM, Loeser JD. Patterns in low back pain hospitalizations: implications for the treatment of low back pain in an era of health care reform. Clin J Pain 1994; 10: 64-70
125. Cherkin DC, Deyo RA, Loeser JD, et al. An international comparison of back surgery rates. Spine 1994; 19: 1201-6
126. Loeser JC, Bigos SJ, Fordyce WE, et al. Low back pain. In: Bonica JJ. editor. The management of pain. 2nd ed. Pennsylvania: Lea and Febiger, 1990: 1448-83
127. North RB, Campbell JN, Names CS, et al. Failed back surgery syndrome: five year follow-up in 102 patients undergoing repeated operation. Neurosurgery 1991; 28: 685-91
128. Walker S, Cousins MJ. Failed back surgery syndrome. Aust Fam Physician 1994; 23: 2308-14
129. Sandstrom J, Esbjornsson E. Return to work after rehabilitation: the significance of the patient's own prediction. Scand J Rehabil Med 1986; 18: 29-33
130. Svensson HO, Andersson GBJ. Low back pain in 40-47-year old men: 1. Frequency of occurrence and impact on medical services. Scand J Rehabil Med 1982; 14: 47
131. Vallfors B. Acute, subacute, and chronic low back pain: clinical symptoms, absenteeism, and working environment. Scand J Rehabil Med 1985; Suppl. 1: 1-98
132. Feuerstein M, Sult S, Houle M. Environmental stressors and chronic low back pain: life events, family and work environment. Pain 1985; 22: 295-307
133. Bigos SJ, Battie MC, Spengler DM. A prospective study of work perceptions and psychosocial factors affecting the report of back injury. Spine 1991; 16: 1-6
134. Feuerstein M, Thebarge RW. Perceptions of disability and occupational stress as discriminators of work disability in patients with chronic pain. J Occup Rehab 1991; 1: 185-95
135. Waddell G, Main CJ. Assessment of severity in low back disorders. Spine 1984; 9: 204-8
136. Milhous RL, Haugh LD, Frymoyer JW, et al. Determinants of vocational disability in patients with low back pain. Arch Phys Med Rehabil 1989; 70: 589-93
137. Sanderson PL. Compensation, work status, and disability in low back pain patients. Spine 1995; 20: 554-6
138. Greenough CG, Fraser RD. The effects of compensation on recovery from low back pain. Spine 1989; 14: 947-55
139. Sander RA, Meyers JE. The relationship of disability to compensation status in railway workers. Spine 1986; 11: 141-3